1. Home
  2. BHB vs ZVRA Comparison

BHB vs ZVRA Comparison

Compare BHB & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bar Harbor Bankshares Inc.

BHB

Bar Harbor Bankshares Inc.

HOLD

Current Price

$37.66

Market Cap

632.2M

Sector

Finance

ML Signal

HOLD

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$13.98

Market Cap

741.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHB
ZVRA
Founded
1887
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
632.2M
741.9M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
BHB
ZVRA
Price
$37.66
$13.98
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$37.00
$23.00
AVG Volume (30 Days)
149.7K
1.8M
Earning Date
04-21-2026
05-06-2026
Dividend Yield
3.95%
N/A
EPS Growth
N/A
159.21
EPS
0.81
0.60
Revenue
N/A
$106,470,000.00
Revenue This Year
$22.68
$37.27
Revenue Next Year
$3.66
$53.42
P/E Ratio
$46.49
$23.30
Revenue Growth
N/A
350.91
52 Week Low
$28.06
$7.16
52 Week High
$39.67
$14.58

Technical Indicators

Market Signals
Indicator
BHB
ZVRA
Relative Strength Index (RSI) 57.09 64.82
Support Level $33.85 $8.26
Resistance Level N/A $14.27
Average True Range (ATR) 1.05 0.60
MACD 0.07 0.06
Stochastic Oscillator 49.87 75.00

Price Performance

Historical Comparison
BHB
ZVRA

About BHB Bar Harbor Bankshares Inc.

Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements, and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, fiduciary services, investment planning, education funding, and individual retirement planning.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: